Skip to main content

Loading market ticker...

Sai Life Sciences (NSE:SAILIFE): What Are the Key Details of Its 27th AGM?

Sai Life Sciences (NSE:SAILIFE): What Are the Key Details of Its 27th AGM?

Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Sai Life Sciences Limited (NSE:SAILIFE) filed an exchange announcement on 24 August 2026 confirming its 27th Annual General Meeting will be held on Thursday, 17 September 2026, at 10:30 A.M. IST via Video Conferencing and Other Audio-Visual Means, with the e-voting cut-off date set at 10 September 2026.

Key Highlights

  • The 27th AGM of Sai Life Sciences Limited will be held on 17 September 2026 at 10:30 A.M. IST through Video Conferencing in accordance with MCA and SEBI circulars.
  • The cut-off date for determining shareholder voting rights is Thursday, 10 September 2026, based on paid-up share value held at close of business on that date.
  • Remote e-voting opens at 9:00 A.M. IST on 14 September 2026 and closes at 5:00 P.M. IST on 16 September 2026, the day before the AGM.
  • The Integrated Annual Report for FY2025-26, including standalone and consolidated financial statements, will be dispatched electronically to all registered email addresses.

About the Company

Sai Life Sciences Limited (NSE:SAILIFE), headquartered in Hyderabad, Telangana, is a contract research and manufacturing services organisation operating in the pharma and healthcare sector. The company provides discovery chemistry, process research, and active pharmaceutical ingredient manufacturing services to global innovator pharmaceutical clients. Its registered office is at IKP Knowledge Park, Turkapally, Hyderabad, and it was incorporated in 1999 under CIN L24110TG1999PLC030970.

Announcement in Detail

The filing, signed by Company Secretary and Compliance Officer Runa Karan (Membership No. A13721), confirms the 27th AGM will be conducted entirely through VC and OAVM in line with applicable MCA and SEBI circulars. The Integrated Annual Report for FY2025-26, comprising the AGM notice, Board's Report, Auditors' Report, and both standalone and consolidated financial statements, will be sent electronically to members with registered email addresses. Members without registered email addresses will receive a letter containing the weblink and detailed path to access the full Annual Report and AGM notice.

Shareholders are entitled to cast their votes electronically on all resolutions placed before the 27th AGM. Voting rights will be determined on the basis of paid-up share value recorded in the member's name at the close of business on the cut-off date of 10 September 2026. Remote e-voting commences at 9:00 A.M. IST on 14 September 2026 and ends at 5:00 P.M. IST on 16 September 2026. The registrar and transfer agent, KFin Technologies Limited, Hyderabad, has been copied on the disclosure.

Impact on Investors

Investors will note that the cut-off date of 10 September 2026 is the legally binding reference point for determining which shareholders are eligible to vote on AGM resolutions. The filing shows that only members holding shares as at the close of business on that date will have voting rights, regardless of any subsequent transfer of shares before the AGM date. Shareholders who have not registered their email addresses with the company, its RTA KFin Technologies, or their Depository Participant are advised to do so to ensure timely receipt of the Annual Report and AGM notice.

The disclosed terms indicate that the AGM will cover resolutions as set out in the AGM notice to be circulated with the Integrated Annual Report. Since the resolutions have not been individually described in this filing, shareholders will observe that reviewing the full AGM notice upon receipt is necessary to assess each resolution before casting an e-vote.

Sector / Market Context

India's contract research and manufacturing services industry has seen sustained growth in recent years, supported by global pharmaceutical companies increasing their outsourcing to Indian CDMO partners. According to FICCI estimates, India's pharmaceutical sector exports crossed USD 27 billion in FY2024, with contract manufacturing contributing a growing share. SEBI's framework for electronic AGMs, maintained since the pandemic-era MCA circulars, continues to allow listed companies to conduct shareholder meetings through VC and OAVM, enabling wider retail participation in corporate governance processes without requiring physical attendance.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.